Gaurav Shah - Nov 21, 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Stock symbol
RCKT
Transactions as of
Nov 21, 2024
Transactions value $
-$144,782
Form type
4
Date filed
11/25/2024, 04:05 PM
Previous filing
Aug 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$145K -11.1K -1.54% $13.05 707K Nov 21, 2024 Direct F1, F2
holding RCKT Common Stock 208K Nov 21, 2024 By Spouse
holding RCKT Common Stock 198K Nov 21, 2024 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.